博瑞生物 (872404.OC)

+ 收藏

利润表(博瑞生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 27,579,521.4152,120,475.2726,753,664.0727,048,469.2822,021,860.84
 营业收入(元) 27,579,521.4152,120,475.2726,753,664.0727,048,469.2822,021,860.84
二、营业总成本(元) 27,285,205.4648,546,653.4026,846,508.3926,004,302.1916,793,663.90
 营业成本(元) 23,418,472.3141,004,818.1822,629,389.1517,520,547.4812,579,851.86
 研发费用(元) 1,150,874.262,653,393.64617,780.042,899,388.781,519,009.93
 营业税金及附加(元) 109,895.88287,619.42164,322.56184,281.78111,678.66
 销售费用(元) 84,327.45151,792.42113,029.1083,523.2539,599.62
 管理费用(元) 1,478,663.222,353,908.141,469,914.072,997,383.511,300,868.95
 财务费用(元) 1,042,972.342,095,121.601,852,073.472,319,177.391,242,654.88
  其中:利息费用(元) 1,037,062.231,936,356.89534,681.722,267,794.391,223,227.19
  其中:利息收入(元) 745.641,290.63650.9418,072.3817,673.42
三、其他经营收益
 信用减值损失(元) -209,069.42-54,570.19333,861.29-209,097.28-2,034,581.11
 其他收益(元) 30,000.00334,090.28106,090.2838,798.61-
四、营业利润(元) 115,246.533,853,341.96347,107.25873,868.423,193,615.83
 减:营业外支出(元) 667.97748,356.84154,428.2224,547.6348.63
五、利润总额(元) 114,578.563,104,985.12192,679.03849,320.793,193,567.20
 减:所得税费用(元) 17,186.78171,467.1978,981.0440,447.91258,865.74
六、净利润(元) 97,391.782,933,517.93113,697.99808,872.882,934,701.46
(一)按经营持续性分类
  持续经营净利润(元) 97,391.782,933,517.93113,697.99808,872.882,934,701.46
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 97,391.782,933,517.93113,697.99808,872.882,934,701.46
 扣除非经常性损益后的净利润(元) 72,559.753,376,059.49177,949.47800,441.692,934,742.80
七、每股收益
 一、基本每股收益(元) -0.05-0.010.05
 二、稀释每股收益(元) -0.05-0.010.05
九、综合收益总额(元) 97,391.782,933,517.93113,697.99808,872.882,934,701.46
 归属于母公司所有者的综合收益总额(元) 97,391.782,933,517.93113,697.99808,872.882,934,701.46
公告日期 2024-08-262024-04-292023-08-282023-04-282022-08-30
审计意见(境内) 带强调事项段的无保留意见保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院